Literature DB >> 15465813

Requirements for DNA unpairing during displacement synthesis by HIV-1 reverse transcriptase.

Jamie Winshell1, Benjamin A Paulson, Ben D Buelow, James J Champoux.   

Abstract

DNA displacement synthesis by reverse transcriptase during retroviral replication is required for the production of the linear precursor to integration. The sensitivity of unpaired thymines to KMnO(4) oxidation was used to probe for the extent of DNA melting by human immunodeficiency virus, type 1 (HIV-1) reverse transcriptase in front of the primer terminus in model oligonucleotide-based displacement constructs. Unpairing of the two base pairs downstream of the primer (+1 and +2 positions) requires the presence of the next correct dNTP, indicating that DNA melting only occurs after the formation of the ternary complex with the enzyme tightly clamped around the DNA. The amount or extent of DNA melting is not significantly affected by the length of the already-displaced strand or the base composition of the DNA beyond the +2 position. The F61W mutant form of HIV-1 reverse transcriptase, which is partially impaired for displacement synthesis, exhibits a reduction in the amount of melting at the +1 and +2 positions. These results demonstrate the importance of the observed melting to displacement synthesis and suggest that the unpairing reaction is mediated by an intimate association between the fingers region of the enzyme and the DNA in the closed clamp conformation of the protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465813     DOI: 10.1074/jbc.M409134200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  DNA-directed DNA polymerase and strand displacement activity of the reverse transcriptase encoded by the R2 retrotransposon.

Authors:  Anna Kurzynska-Kokorniak; Varuni K Jamburuthugoda; Arkadiusz Bibillo; Thomas H Eickbush
Journal:  J Mol Biol       Date:  2007-09-20       Impact factor: 5.469

Review 2.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

Review 3.  Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies.

Authors:  Abhimanyu K Singh; Kalyan Das
Journal:  Viruses       Date:  2022-05-11       Impact factor: 5.818

4.  Single-molecule study of DNA polymerization activity of HIV-1 reverse transcriptase on DNA templates.

Authors:  Sangjin Kim; Charles M Schroeder; X Sunney Xie
Journal:  J Mol Biol       Date:  2009-12-04       Impact factor: 5.469

5.  Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo.

Authors:  Benjamin A Paulson; Miaohua Zhang; Sharon J Schultz; James J Champoux
Journal:  Virology       Date:  2007-05-29       Impact factor: 3.616

6.  Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates.

Authors:  Shixin Liu; Elio A Abbondanzieri; Jason W Rausch; Stuart F J Le Grice; Xiaowei Zhuang
Journal:  Science       Date:  2008-11-14       Impact factor: 47.728

7.  Reverse transcriptases can clamp together nucleic acids strands with two complementary bases at their 3'-termini for initiating DNA synthesis.

Authors:  Iris Oz-Gleenberg; Alon Herschhorn; Amnon Hizi
Journal:  Nucleic Acids Res       Date:  2010-09-28       Impact factor: 16.971

8.  Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function.

Authors:  Dibyakanti Mandal; Chandravanu Dash; Stuart F J Le Grice; Vinayaka R Prasad
Journal:  Nucleic Acids Res       Date:  2006-05-24       Impact factor: 16.971

9.  Interactions between HIV-1 reverse transcriptase and the downstream template strand in stable complexes with primer-template.

Authors:  Wiriya Rutvisuttinunt; Peter R Meyer; Walter A Scott
Journal:  PLoS One       Date:  2008-10-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.